Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550457904> ?p ?o ?g. }
- W2550457904 endingPage "e1249558" @default.
- W2550457904 startingPage "e1249558" @default.
- W2550457904 abstract "The successful use of immune cell checkpoint inhibitors PD-1 and PD-L1, over the past 5 y has raised the concern of using immunotherapy to treat various cancers. Epstein-Barr virus-associated gastric cancer (EBVaGC) exhibits high infiltration of lymphocytes and high amplification of immune-related genes including PD-L1 as distinguished from Epstein-Barr virus-non-associated gastric cancer (EBVnGC). Here, we presume that this PD-1/PD-L1 pathway may hinder the efficacy of adoptive T cell therapy toward EBVaGC. These studies reveal possibility of generating PD-1-disrupted CTL by CRISPR-Cas9 system and demonstrate enhanced immune response of these PD-1-disrupted CTLs to the EBV-LMP2A antigen and superior cytotoxicity to the EBV-positive gastric cancer cell. In addition, when combined with low-dose radiotherapy, these PD-1-disrupted CTLs mediated an impressive antitumor effect in a xenograft mouse model of EBVaGC. Taken together, these studies illustrate PD-1/PD-L1-mediated immune tolerance of EBVaGC and provide a new strategy for targeting immune checkpoints to break the tolerance for the T cell-based adoptive therapy." @default.
- W2550457904 created "2016-11-30" @default.
- W2550457904 creator A5003040978 @default.
- W2550457904 creator A5004716187 @default.
- W2550457904 creator A5030659990 @default.
- W2550457904 creator A5033420311 @default.
- W2550457904 creator A5033970223 @default.
- W2550457904 creator A5038014902 @default.
- W2550457904 creator A5044549205 @default.
- W2550457904 creator A5045364810 @default.
- W2550457904 creator A5045723123 @default.
- W2550457904 creator A5049692788 @default.
- W2550457904 creator A5056700500 @default.
- W2550457904 creator A5057361452 @default.
- W2550457904 creator A5059386730 @default.
- W2550457904 creator A5064430125 @default.
- W2550457904 creator A5085558954 @default.
- W2550457904 date "2016-11-22" @default.
- W2550457904 modified "2023-10-11" @default.
- W2550457904 title "CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer" @default.
- W2550457904 cites W1498454097 @default.
- W2550457904 cites W1755269379 @default.
- W2550457904 cites W1864189603 @default.
- W2550457904 cites W1940241680 @default.
- W2550457904 cites W1976269164 @default.
- W2550457904 cites W1982488143 @default.
- W2550457904 cites W1988769531 @default.
- W2550457904 cites W1999075493 @default.
- W2550457904 cites W2006646444 @default.
- W2550457904 cites W2008062656 @default.
- W2550457904 cites W2012420584 @default.
- W2550457904 cites W2022208959 @default.
- W2550457904 cites W2023269331 @default.
- W2550457904 cites W2037972262 @default.
- W2550457904 cites W2038651111 @default.
- W2550457904 cites W2042797183 @default.
- W2550457904 cites W2045435533 @default.
- W2550457904 cites W2049553585 @default.
- W2550457904 cites W2060001883 @default.
- W2550457904 cites W2079018735 @default.
- W2550457904 cites W2080817801 @default.
- W2550457904 cites W2083853617 @default.
- W2550457904 cites W2089589904 @default.
- W2550457904 cites W2098746033 @default.
- W2550457904 cites W2100928937 @default.
- W2550457904 cites W2104350866 @default.
- W2550457904 cites W2108334708 @default.
- W2550457904 cites W2112121482 @default.
- W2550457904 cites W2119786935 @default.
- W2550457904 cites W2125135959 @default.
- W2550457904 cites W2125616358 @default.
- W2550457904 cites W2129806226 @default.
- W2550457904 cites W2132564070 @default.
- W2550457904 cites W2133057192 @default.
- W2550457904 cites W2147240268 @default.
- W2550457904 cites W2156353875 @default.
- W2550457904 cites W2159094759 @default.
- W2550457904 cites W2166662937 @default.
- W2550457904 cites W2168209011 @default.
- W2550457904 cites W2247762492 @default.
- W2550457904 cites W2257916459 @default.
- W2550457904 cites W2298468092 @default.
- W2550457904 cites W2396078929 @default.
- W2550457904 cites W42374714 @default.
- W2550457904 doi "https://doi.org/10.1080/2162402x.2016.1249558" @default.
- W2550457904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5283615" @default.
- W2550457904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28197365" @default.
- W2550457904 hasPublicationYear "2016" @default.
- W2550457904 type Work @default.
- W2550457904 sameAs 2550457904 @default.
- W2550457904 citedByCount "67" @default.
- W2550457904 countsByYear W25504579042017 @default.
- W2550457904 countsByYear W25504579042018 @default.
- W2550457904 countsByYear W25504579042019 @default.
- W2550457904 countsByYear W25504579042020 @default.
- W2550457904 countsByYear W25504579042021 @default.
- W2550457904 countsByYear W25504579042022 @default.
- W2550457904 countsByYear W25504579042023 @default.
- W2550457904 crossrefType "journal-article" @default.
- W2550457904 hasAuthorship W2550457904A5003040978 @default.
- W2550457904 hasAuthorship W2550457904A5004716187 @default.
- W2550457904 hasAuthorship W2550457904A5030659990 @default.
- W2550457904 hasAuthorship W2550457904A5033420311 @default.
- W2550457904 hasAuthorship W2550457904A5033970223 @default.
- W2550457904 hasAuthorship W2550457904A5038014902 @default.
- W2550457904 hasAuthorship W2550457904A5044549205 @default.
- W2550457904 hasAuthorship W2550457904A5045364810 @default.
- W2550457904 hasAuthorship W2550457904A5045723123 @default.
- W2550457904 hasAuthorship W2550457904A5049692788 @default.
- W2550457904 hasAuthorship W2550457904A5056700500 @default.
- W2550457904 hasAuthorship W2550457904A5057361452 @default.
- W2550457904 hasAuthorship W2550457904A5059386730 @default.
- W2550457904 hasAuthorship W2550457904A5064430125 @default.
- W2550457904 hasAuthorship W2550457904A5085558954 @default.
- W2550457904 hasBestOaLocation W25504579041 @default.
- W2550457904 hasConcept C104317684 @default.
- W2550457904 hasConcept C121608353 @default.
- W2550457904 hasConcept C126322002 @default.